IRIS
GIANNONI, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.962
EU - Europa 9.859
AS - Asia 8.965
SA - Sud America 2.466
AF - Africa 210
Continente sconosciuto - Info sul continente non disponibili 28
OC - Oceania 24
Totale 38.514
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.060
SG - Singapore 3.906
RU - Federazione Russa 3.436
CN - Cina 2.079
BR - Brasile 2.020
GB - Regno Unito 1.678
IT - Italia 1.622
VN - Vietnam 1.238
DE - Germania 792
CA - Canada 695
HK - Hong Kong 609
UA - Ucraina 607
SE - Svezia 310
DK - Danimarca 270
IE - Irlanda 178
FI - Finlandia 177
AR - Argentina 176
FR - Francia 176
IL - Israele 168
NL - Olanda 160
IN - India 159
PL - Polonia 156
MX - Messico 150
BD - Bangladesh 140
TR - Turchia 121
ID - Indonesia 110
EC - Ecuador 101
ES - Italia 89
JP - Giappone 87
ZA - Sudafrica 79
PK - Pakistan 74
IQ - Iraq 71
AT - Austria 68
LT - Lituania 38
MA - Marocco 37
UZ - Uzbekistan 36
CO - Colombia 34
AE - Emirati Arabi Uniti 33
VE - Venezuela 30
EU - Europa 27
PY - Paraguay 27
CL - Cile 26
KE - Kenya 19
PE - Perù 19
UY - Uruguay 19
TN - Tunisia 17
EG - Egitto 15
RO - Romania 15
SA - Arabia Saudita 15
BE - Belgio 14
NP - Nepal 12
AU - Australia 10
AZ - Azerbaigian 10
CH - Svizzera 10
HN - Honduras 10
DZ - Algeria 9
NZ - Nuova Zelanda 9
TH - Thailandia 9
DO - Repubblica Dominicana 8
JO - Giordania 8
BO - Bolivia 7
CZ - Repubblica Ceca 7
KG - Kirghizistan 7
KR - Corea 7
KZ - Kazakistan 7
PH - Filippine 7
TW - Taiwan 7
BG - Bulgaria 6
IR - Iran 6
NI - Nicaragua 6
CR - Costa Rica 5
GE - Georgia 5
GY - Guiana 5
JM - Giamaica 5
MG - Madagascar 5
MT - Malta 5
PA - Panama 5
PS - Palestinian Territory 5
QA - Qatar 5
TT - Trinidad e Tobago 5
AO - Angola 4
CI - Costa d'Avorio 4
DM - Dominica 4
ET - Etiopia 4
GR - Grecia 4
HU - Ungheria 4
OM - Oman 4
RS - Serbia 4
AL - Albania 3
AM - Armenia 3
BY - Bielorussia 3
GD - Grenada 3
LU - Lussemburgo 3
LV - Lettonia 3
LY - Libia 3
NG - Nigeria 3
NO - Norvegia 3
PT - Portogallo 3
SI - Slovenia 3
BA - Bosnia-Erzegovina 2
Totale 38.462
Salva come PNG Salva come JPEG
Città #
Dallas 3.694
Singapore 2.041
Ashburn 1.051
Beijing 1.032
Southend 907
Chandler 733
Moscow 594
Fairfield 584
Houston 536
Los Angeles 524
Hong Kong 499
Woodbridge 469
San Mateo 436
Ann Arbor 422
Chicago 415
Falls Church 406
Seattle 362
Ho Chi Minh City 357
Cambridge 331
Jacksonville 323
Wilmington 315
The Dalles 263
New York 258
Ottawa 255
Boardman 218
Hefei 215
Dearborn 214
Hanoi 214
São Paulo 212
Buffalo 185
Dublin 176
Salt Lake City 173
Pisa 172
Portsmouth 170
Stevenage 164
Beauharnois 163
Tel Aviv 152
Munich 149
Dong Ket 147
Santa Clara 143
Warsaw 143
Lawrence 132
Milan 129
Rome 129
London 118
Brooklyn 109
Montreal 97
Stockholm 86
Denver 82
Orem 82
Poplar 81
Tampa 81
Tokyo 78
Atlanta 75
Montréal 72
Chennai 70
Elk Grove Village 68
Istanbul 66
Frankfurt am Main 64
Johannesburg 62
Rio de Janeiro 62
San Diego 61
Nuremberg 60
Mexico City 59
Phoenix 58
Florence 57
Fremont 53
Helsinki 53
Toronto 51
Boston 48
Amsterdam 45
Turku 44
Council Bluffs 42
Da Nang 41
Manchester 41
San Francisco 41
Brasília 39
Guayaquil 39
Redwood City 39
Ankara 38
Haiphong 38
Dongguan 36
Tashkent 36
Belo Horizonte 35
Lappeenranta 34
Lancaster 33
Biên Hòa 32
Curitiba 32
Querétaro 32
Sterling 32
Genoa 31
Ariccia 30
Campinas 29
Porto Alegre 29
San Jose 29
Guangzhou 28
Quito 28
Vienna 28
Bologna 27
Old Bridge 27
Totale 23.095
Salva come PNG Salva come JPEG
Nome #
N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosis 1.600
Left ventricular outflow tract velocity-time integral improves outcome prediction in patients with secondary mitral regurgitation 453
A cross-correlational analysis between electroencephalographic and end-tidal carbon dioxide signals: Methodological issues in the presence of missing data and real data results 444
Prognostic Significance of Central Apneas Throughout a 24-Hour Period in Patients With Heart Failure 361
A simple method for measuring baroreflex sensitivity holds prognostic value in heart failure 313
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease 312
A simple echocardiographic score to rule out cardiac amyloidosis 307
Central sleep apnea and cardiovascular disease state-of-the-art 302
"Targeting and Treating Apneas" in "The Breathless Heart: Apneas in Heart Failure" 295
Treating chemoreflex in heart failure: modulation or demolition? 293
"To Breathe, or Not to Breathe: That Is the Question" in "The Breathless Heart: Apneas in Heart Failure" 290
Abnormal hyperventilation in patients with hepatic cirrhosis: Role of enhanced chemosensitivity to carbon dioxide. 289
Peripheral reflex feedbacks in chronic heart failure: Is it time for a direct treatment? 285
Influence of central apneas and chemoreflex activation on pulmonary artery pressure in chronic heart failure 281
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers 281
Adrenergic activation in heart failure: blockade or rebalance? 276
Adaptive servo-ventilation therapy does not favourably alter sympatho-vagal balance in sleeping patients with systolic heart failure and central apnoeas: Preliminary data 269
Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches 269
Prediction of the chemoreflex gain by common clinical variables in heart failure 262
An analysis of fMRI signal during voluntary breath hold and carbon dioxide challenge: physiological correction and modeling issues 261
A novel echocardiographic method for estimation of pulmonary artery wedge pressure and pulmonary vascular resistance 261
A simple echocardiographic score to rule out cardiac amyloidosis 258
Galectin-3 and myocardial fibrosis in nonischemic dilated cardiomyopathy 258
Glycosylated haemoglobin is associated with neurohormonal activation and poor outcome in chronic heart failure patients with mild left ventricular systolic dysfunction 255
[Central apneas and cardiovascular diseases] 253
AEROBIC TRAINING DECREASES AORTIC STIFFNESS IN PATIENTS WITH HEART FAILURE 253
After the SERVE-HF Trial, Is There Still a Need for Treatment of Central Apnea? 250
An open computational toolbox to analyze multi- and single-unit sympathetic nerve activity in microneurography 245
Comparison of Brain Natriuretic Peptide (BNP) and amino-terminal ProBNP for early diagnosis of heart failure 243
Clinical relevance of non-cardiac determinants of natriuretic peptide levels. 237
How to take arms against central apneas in heart failure 234
Cheyne-Stokes respiration related oscillations in cardiopulmonary hemodynamics in patients with heart failure 232
Statin intolerance in heterozygous familial hypercolesterolemia with cardiovascular disease: After PCSK-9 antibodies what else? 231
B-type natriuretic peptide secretion following scuba diving 228
COVID-19 and risk of pulmonary fibrosis: the importance of planning ahead 227
Myocardial damage in a mitochondrial myopathy patient with increased ergoreceptor sensitivity and sympatho-vagal imbalance 226
An atypical case of cardiac amyloidosis. 222
Models of BOLD Signal Change in Breath Hold Studies and CO2 Challenges: Methodological Issues and Interpretation 221
Screening the health status of people working in a university 219
Improved survival in limited scleroderma-related pulmonary artery hypertension 219
Body mass index and outcomes in ischaemic versus non-ischaemic heart failure across the spectrum of ejection fraction 219
Effects of nasal high flow on sympathovagal balance, sleep, and sleep-related breathing in patients with precapillary pulmonary hypertension 217
NT-proBNP prognostic value is maintained in elderly and very elderly patients with chronic systolic heart failure 215
Effect of Sex on Reverse Remodeling in Chronic Systolic Heart Failure 215
Neurohormonal modulation for treatment of cardiac involvement in dystrophinopathies and mitochondrial disease 214
Acute right-sided transcutaneous vagus nerve stimulation improves cardio-vagal baroreflex gain in patients with chronic heart failure 213
Oxidative stress and inflammation in the evolution of heart failure: From pathophysiology to therapeutic strategies 210
Diaphragm function does not independently predict exercise intolerance in patients with precapillary pulmonary hypertension after adjustment for right ventricular function 210
Circulating levels and prognostic cut-offs of sST2, hs-cTnT, and NT-proBNP in women vs. men with chronic heart failure 208
The extent and location of late gadolinium enhancement predict defibrillator shock and cardiac mortality in patients with non-ischaemic dilated cardiomyopathy 208
Correlational analysis of electroencephalographic and end-tidal carbon dioxide signals during breath-hold exercise 208
Changes in chemoreflex characteristics following acetazolamide administration in patients with chronic heart failure and Cheyne Stokes respiration 207
In Vivo Murine Models of Cardiotoxicity Due to Anticancer Drugs: Challenges and Opportunities for Clinical Translation 207
Central And Obstructive Apneas in Heart Failure With Reduced, Mid-Range And Preserved Ejection Fraction. 206
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 206
Contribution of the lung to the genesis of cheyne-stokes respiration in heart failure: Plant gain beyond chemoreflex gain and circulation time 206
Echocardiography-Derived Forward Left Ventricular Output Improves Risk Prediction in Systolic Heart Failure 205
Cheyne-Stokes Respiration, Chemoreflex, and Ticagrelor-Related Dyspnea 205
Prognostic value of reverse remodelling criteria in heart failure with reduced or mid-range ejection fraction 204
Unveiling a sudden unexplained death case by whole exome sequencing and bioinformatic analysis 203
Heart Failure Results in Inspiratory Muscle Dysfunction Irrespective of Left Ventricular Ejection Fraction 203
Cheyne-Stokes respiration is associated with neurohormonal activation in patients with heart failure 202
High-risk NSTEMI due to subclavian artery atherothrombosis in a prior coronary artery bypass graft patient 201
Risk factors and prognostic value of daytime Cheyne-Stokes respiration in chronic heart failure patients 199
APAP therapy does not improve impaired sleep quality and sympatho-vagal balance: a randomized trial in patients with obstructive sleep apnea and systolic heart failure 199
Prognostic value of plasma Renin activity in heart failure. 198
Diagnosis of preclinical /mild heart failure with B-type natriuretic peptides: compariosn betwwen BNP and NT-proBNP immunoassay methods 196
Reversal of ticagrelor-induced arrhythmias and cheyne-stokes respiration with aminophylline infusion 195
A Novel Homozygous Mutation of the Desmoplakin Gene With Biventricular Arrhythmogenic Cardiomyopathy 195
Automatic analysis of EEG pattern during sleep in Cheyne-Stokesrespiration in heart failure. 194
Ld-EEG Effective Brain Connectivity in Patients With Cheyne-Stokes Respiration 193
Pathophysiology of Central Apneas in Heart Failure 192
Effects of central apneas on sympathovagal balance and hemodynamics at night: impact of underlying systolic heart failure 192
Sympathetic and Vagal Nerve Activity in COPD: Pathophysiology, Presumed Determinants and Underappreciated Therapeutic Potential 191
Eligibility for vericiguat in a real‐world, contemporary heart failure population 191
Breath-hold task induces temporal heterogeneity in electroencephalographic regional field power in healthy subjects 191
Mapping dependencies of BOLD signal change to end-tidal CO2: Linear and nonlinear modeling, and effect of physiological noise correction 191
Arrhythmic risk prediction in non-dilated left ventricular cardiomyopathy: The role of overlap with arrhythmogenic cardiomyopathy 189
Exploratory analysis of nonlinear coupling between EEG global field power and end-tidal carbon dioxide in free breathing and breath-hold tasks 189
Clinical significance of chemosensitivity in chronic heart failure: influence on neurohormonal derangement, Cheyne-Stokes respiration and arrhythmias. 187
Permanent atrial fibrillation affects exercise capacity in chronic heart failure patients. 187
Effect of acetazolamide on chemosensitivity, Cheyne-Stokes respiration, and response to effort in patients with heart failure. 187
Modern diagnostic and therapeutical approach to cardiac AL amyloidosis and neuroendocrine model of heart failure: lessons from a clinical case. 187
Noncardiac Versus Cardiac Mortality in Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction 186
On the Use of Linear-Modelling-based Algorithms for Physiological Noise Correction in fMRI Studies of the Central Breathing Control 184
Myocardial Infarction Following COVID-19 Vaccine Administration: Post Hoc, Ergo Propter Hoc? 184
Breathless heart: only when the neck is deep in water? 183
Clinical and prognostic significance of central and obstructive apnoeas in patients with transthyretin cardiac amyloidosis 182
The ergoreflex: how the skeletal muscle modulates ventilation and cardiovascular function in health and disease 182
Role of Imaging in Cardiomyopathies 181
Prognostic value of right ventricular refractory period heterogeneity in Type-1 Brugada electrocardiographic pattern 181
When the heart is burning: Amino-terminal pro-brain natriuretic peptide as an early marker of cardiac involvement in active autoimmune rheumatic disease 180
Sacubitril–valsartan treatment is associated with decrease in central apneas in patients with heart failure with reduced ejection fraction 180
The Importance of Visceral Feedbacks: Focus on Chemoreceptors 180
Central apnoeas and ticagrelor-related dyspnoea in patients with acute coronary syndrome 180
Thirty years of the heart as an endocrine organ: physiological role and clinical utility of cardiac natriuretic hormones 179
Upright Cheyne-Stokes Respiration in Patients With Heart Failure 179
Impact of Simulated Hyperventilation and Periodic Breathing on Sympatho-Vagal Balance and Hemodynamics in Patients with and without Heart Failure 178
Baroreflex sensitivity, assessed by a novel noninvasive method, holds prognostic value in systolic heart failure 177
Analysis of generic coupling between EEG activity and PETCO2 in free breathing and breath-hold tasks using Maximal Information Coefficient (MIC) 177
Totale 23.923
Salva come PNG Salva come JPEG
Categoria #
all - tutte 203.057
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 203.057
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.127 0 0 0 0 0 542 330 217 177 207 198 456
2021/20222.330 146 385 113 278 71 43 239 431 151 247 55 171
2022/20231.643 133 154 83 209 220 243 17 143 253 32 81 75
2023/20241.162 107 34 280 90 37 88 80 49 30 39 39 289
2024/202510.696 65 80 466 207 596 585 1.383 2.351 871 949 1.993 1.150
2025/202615.996 1.363 4.006 2.931 3.638 2.944 1.114 0 0 0 0 0 0
Totale 38.774